Related Articles

Positive Study Results Give New Hope for Alzheimer’s Patients

Alzheimer’s patients and their loved ones have new reason for hope after positive results from clinical trial of a new treatment called lecanemab. Lecanemab – a drug designed to slow the progression of Alzheimer’s disease by targeting amyloid plaque buildup in the brain – reduced the progression of cognitive decline among trial participants by 27% …
The post Positive Study Results Give New Hope for Alzheimer’s Patients appeared first on Salud America.

Take Charge of Your Brain Health — For You and Your Loved Ones

The Arizona Department of Health Services (ADHS) joins the Alzheimer’s Association® in encouraging Arizonans to take proactive steps toward protecting their brain health and reducing the risk of cognitive decline.  More than 7 million Americans are currently living with Alzheimer’s disease. In Arizona, this number is growing, with our aging population especially at risk. Two-thirds […]

Responses